Impact ofCOX2genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Impact ofCOX2genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 135, Issue 8, Pages 1898-1910
Publisher
Wiley
Online
2014-03-06
DOI
10.1002/ijc.28831
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Coffee prevents early events in tamoxifen-treated breast cancer patients and modulates hormone receptor status
- (2013) Maria Simonsson et al. CANCER CAUSES & CONTROL
- The association of breast density with breast cancer mortality in African American and white women screened in community practice
- (2012) Shengfan Zhang et al. BREAST CANCER RESEARCH AND TREATMENT
- Given breast cancer, does breast size matter? Data from a prospective breast cancer cohort
- (2012) Andrea Markkula et al. CANCER CAUSES & CONTROL
- The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality
- (2012) Danny R. Youlden et al. Cancer Epidemiology
- Clinical Profiles Predict Early Nonadherence to Adjuvant Endocrine Treatment in a Prospective Breast Cancer Cohort
- (2012) A. Markkula et al. Cancer Prevention Research
- ‘Metabolically healthy obesity’: Origins and implications
- (2012) Gerald V. Denis et al. MOLECULAR ASPECTS OF MEDICINE
- Minireview: Inflammation: An Instigator of More Aggressive Estrogen Receptor (ER) Positive Breast Cancers
- (2012) Sarah C. Baumgarten et al. MOLECULAR ENDOCRINOLOGY
- Volumetric breast density characteristics as determined from digital mammograms
- (2012) O Alonzo-Proulx et al. PHYSICS IN MEDICINE AND BIOLOGY
- Increased Levels of COX-2 and Prostaglandin E 2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women
- (2012) Kotha Subbaramaiah et al. Cancer Discovery
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- Difference in hormone receptor content in breast cancers from Vietnamese and Swedish women
- (2011) Vu Hong Thang et al. ACTA ONCOLOGICA
- Polymorphisms in cycloxygenase-2 gene and breast cancer prognosis: association between PTGS2 haplotypes and histopathological features
- (2011) Juliana S. Festa-Vasconcellos et al. BREAST CANCER RESEARCH AND TREATMENT
- Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
- (2011) Patrick G. Morris et al. Cancer Prevention Research
- Cyclooxygenase-2 Polymorphisms and Pancreatic Cancer Susceptibility
- (2011) Gül Özhan et al. PANCREAS
- COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer
- (2010) Sharon A Glynn et al. BMC CANCER
- COX2 expression in prognosis and in prediction to endocrine therapy in early breast cancer patients
- (2010) Johanna G. H. van Nes et al. BREAST CANCER RESEARCH AND TREATMENT
- Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists
- (2010) Sara J. Schonfeld et al. CANCER CAUSES & CONTROL
- Association of Body Size Measurements and Mammographic Density in Korean Women: The Healthy Twin Study
- (2010) J. Sung et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effect of Baseline Breast Density on Breast Cancer Incidence, Stage, Mortality, and Screening Parameters: 25-Year Follow-up of a Swedish Mammographic Screening
- (2010) S. Y. H. Chiu et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward
- (2010) D. G. Menter et al. CLINICAL CANCER RESEARCH
- Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis
- (2009) Ke-Da Yu et al. BREAST CANCER RESEARCH AND TREATMENT
- CYP2C8 and CYP2C9 polymorphisms in relation to tumour characteristics and early breast cancer related events among 652 breast cancer patients
- (2009) H Jernström et al. BRITISH JOURNAL OF CANCER
- Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence--Data from a Randomized Clinical Trial
- (2009) E. L. Barry et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic Variation in Immune Regulation and DNA Repair Pathways and Stomach Cancer in China
- (2009) S. K. Hussain et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Does Breast Size Modify the Association between Mammographic Density and Breast Cancer Risk?
- (2008) A. Stuedal et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Coffee Consumption and CYP1A2*1F Genotype Modify Age at Breast Cancer Diagnosis and Estrogen Receptor Status
- (2008) E. Bageman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?
- (2008) Carina Pereira et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Randomized Clinical Trials and Observational Studies
- (2008) Edward L. Hannan JACC-Cardiovascular Interventions
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started